Juluca 50-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FSVG1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,694
Award facts
- Contract value 100% obligated
- $12,694.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,694.32 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of JULUCA 50-25 mg tablets (30-unit packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of November 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of federal contracts covering numerous therapeutic domains, from specialty medications and vaccines to medical devices and diagnostic supplies. JULUCA, an antiretroviral medication used in HIV treatment, represents one of many pharmaceutical products the contractor supplies through its DLA partnerships. As a non-set-aside award, this contract demonstrates AmerisourceBergen's continued capability to compete successfully for federal pharmaceutical procurement requirements and fulfill the Defense Logistics Agency's medical supply chain needs.
Quick answers
Who was awarded contract SPE2DR26FSVG1?
SPE2DR26FSVG1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FSVG1 worth?
The government has obligated $12,694 on SPE2DR26FSVG1.
Is contract SPE2DR26FSVG1 an order under another contract?
Yes. SPE2DR26FSVG1 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSVG1 competed?
The extent of competition for SPE2DR26FSVG1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award